BETA Technologies Q2 Revenue Soars 146%, Raises Full-Year Guidance to $42M-$48M
BETA sits 62% above its 52-week low of $13.43.
Summary
BETA Technologies' Q2 revenue surged 146% to $14.7M, and it raised full-year guidance to $42M-$48M. Losses widened on heavy R&D spend, but $1.48B in cash provides a long runway.
Key Events · Earnings and Guidance · BETA
-
Revenue Surges 146%
Q2 2026 revenue hit $14.7M, up from $6.0M a year ago, driven by $11.4M in service revenue from engineering contracts and charging station access.
-
Full-Year Guidance Raised
Management lifted 2026 revenue guidance to $42M-$48M, up from prior expectations, reflecting growing commercial and government demand.
-
Losses Widen on R&D Spend
Net loss grew to $148.8M from $80.4M, as R&D expenses more than doubled to $122.4M, including a $15M IPR&D charge from the Biocogniv acquisition.
-
Strong Cash Position
Cash and equivalents stood at $1.48B as of June 30, 2026, down $231M from year-end 2025, providing multi-year runway despite heavy cash burn.
Analysis · BETA · Manufacturing
BETA Technologies reported Q2 2026 revenue of $14.7 million, a 146% jump from a year ago, driven by engineering services and charging station access. The company raised its full-year revenue outlook to $42 million to $48 million, up from prior guidance, signaling accelerating commercial traction. However, operating losses widened to $158 million as R&D spending more than doubled, reflecting heavy investment in aircraft certification and the new MV250 military drone. With $1.48 billion in cash, the company has ample runway but is burning roughly $170 million per half-year. The CEO and COO also adopted new 10b5-1 trading plans, adding to a pattern of insider selling that may temper enthusiasm.
At the time of this filing, BETA was trading at $21.82 on NYSE in the Manufacturing sector, with a market capitalization of approximately $5B. The 52-week trading range was $13.43 to $39.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.